Skip to content

News Category: Health & Medical

Turn Biotechnologies Introduces its Dermatology Platform to the European Aesthetic Community at AMWC

By asianet

Turn Biotechnologies, a cell rejuvenation company developing novel mRNA medicines to cure untreatable, age-related conditions, announced that it will for the first time share new data for its revolutionary dermatology platform with the international regenerative aesthetic community. Photo – https://mma.prnewswire.com/media/2043671/sebastiano_campus_high_resolution.jpg Logo – https://mma.prnewswire.com/media/1935529/TURN_LOGO_HI_RES_Logo.jpg Evidence-based data showing the global regenerative efficacy of Turn Bio’s Epigenetic Reprogramming … Continued

Hovione and Laxxon Medical Establish an Agreement for the cGMP Production of 3D Screen Printed Pharmaceutical Applications

By asianet

This partnership will create an opportunity for the pharmaceutical industry to develop and manufacture clinical materials and secure industrial scale production under cGMP with Hovione, using Laxxon Medical’s 3D screen printing technology. Hovione and Laxxon Medical announced a strategic collaboration to advance the use of 3D screen printing technologies for the pharmaceutical industry. This partnership … Continued

Hovione and Ripple Enter Strategic Partnership to Expand Epidel(R) Platform into Non-Ophthalmic Space

By asianet

Hovione, the specialist integrated CDMO, leader in spray drying and particle engineering, and Ripple Therapeutics, a leading ophthalmic sustained drug delivery company, have entered a strategic partnership to expand the use of Ripple’s Epidel(R) platform beyond ophthalmic applications. The core feature of Ripple’s Epidel(R) technology is the ability to deliver sustained-release pharmaceuticals with surface erosion … Continued

Sai Life Sciences sets up GMP Kilo Lab in Alderley Park, Manchester, UK

By asianet

Sai Life Sciences, a leading global Contract Research, Development & Manufacturing Organization (CRO-CDMO)[https://www.sailife.com/?utm_source=pr&utm_medium=web&utm_campaign=manchester-kilolab], today announced the setting up of a GMP Kilo Lab at its facility in Alderley Park, Manchester, UK. The new GMP Kilo Lab will enable Sai Life Sciences to offer drug substance and intermediates supplies ranging from gram to kilogram quantities to … Continued

Nippon Express (Belgium) Joins Pharma.Aero

By asianet

Nippon Express (Belgium) N.V./S.A. (hereinafter “NX Belgium”), a group company of NIPPON EXPRESS HOLDINGS, INC., became the first Japanese forwarder to join Pharma.Aero (*) on January 25 this year. Pharma.Aero logo: https://kyodonewsprwire.jp/img/202303033576-O1-98z3VY1t NIPPON EXPRESS logo: https://kyodonewsprwire.jp/img/202303033576-O2-Liv03U6J The Nippon Express Group has positioned the pharmaceutical industry as a key industry in its “Nippon Express Group Business … Continued

Ajinomoto Bio-Pharma Services Awarded Three ‘CDMO Leadership Awards’

By asianet

Ajinomoto Bio-Pharma Services (“Aji Bio-Pharma”), a leading provider of biopharmaceutical contract development and manufacturing services, received three CDMO Leadership Awards in the categories Capabilities, Compatibility, and Expertise in both the Overall and Big Pharma respondent groups. Logo – https://mma.prnewswire.com/media/751177/Aji_BioPharma_Logo.jpg Established in 2011, the CDMO Leadership Awards recognize top outsourcing partners. The awards, rebranded from the … Continued

Albumedix and Heartseed announce Recombumin(R) as a critical excipient in the manufacture of Heartseed’s HS-001 investigational cell therapy as its first in-human trial commences

By asianet

Albumedix Ltd (‘Albumedix’), Nottingham, United Kingdom, now part of the global life science group Sartorius, and Heartseed Inc (‘Heartseed’), Tokyo, Japan, Tuesday 14th March 2023, announce that Recombumin(R) is a critical component of Heartseed’s HS-001, an investigational cardiac remuscularization cell therapy which has commenced first in human dosing. – Recombumin, an animal and human origin … Continued

NCODA International Executive Council to Advance Medically Integrated Oncology Worldwide

By asianet

NCODA ( https://c212.net/c/link/?t=0&l=en&o=3800098-1&h=2079229491&u=https%3A%2F%2Fwww.ncoda.org%2F&a=NCODA ) a non-profit organization whose Mission is to empower the medically-integrated oncology team to deliver positive, patient-centered outcomes is proud to announce the formation of its International Executive Council (IEC). The IEC will provide insight and leadership to NCODA regarding meeting the ever-changing needs of oncology patients and healthcare professionals around the … Continued

NIPPON EXPRESS HOLDINGS Strengthens Pharmaceutical Logistics Quality System Globally

By asianet

– Compiles “NX-Pharma Global Quality Manual” and Appoints Head of NX-Pharma Global Quality – NIPPON EXPRESS HOLDINGS, INC., based in Tokyo, has compiled the NX-Pharma Global Quality Manual, applicable as of Sunday, January 1, 2023, to unify and standardize pharmaceutical logistics quality standards on a global basis. Logo: https://kyodonewsprwire.jp/img/202303013462-O1-7reh962D Image: NX-Pharma Global Quality Manual https://kyodonewsprwire.jp/prwfile/release/M103866/202303013462/_prw_PI2fl_yksd5VnD.jpg … Continued

Mallinckrodt Announces Reimbursement Approval in Japan for the CELLEX(R) Extracorporeal Photopheresis (ECP) System for the Treatment of Chronic Graft Versus Host Disease (cGvHD)

By asianet

– CELLEX ECP is now available for reimbursement in Japan for patients who are steroid-resistant or -intolerant and suffering from cGvHD – Mallinckrodt plc ( https://c212.net/c/link/?t=0&l=en&o=3801942-1&h=3085666488&u=http%3A%2F%2Fwww.mallinckrodt.com%2F&a=Mallinckrodt+plc ), (NYSE American: MNK) (“Mallinckrodt” or the “Company”), a global specialty pharmaceutical company, today announced that Japan’s National Health Insurance (NHI) system has approved reimbursement for the CELLEX(R) extracorporeal … Continued